Antibodies to Pathogenic Epitopes on Type XVII Collagen Cause Skin Fragility in a Complement-Dependent and -Independent Manner

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Immunology

• Publication date

  2012-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.4049/jimmunol.1003402PMID 22523387
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathogenesis of bullous pemphigoid.

  2012cited by this paper
• Ultrastructure and molecular pathogenesis of epidermolysis bullosa.

  2011cited by this paper
• Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study.

  2011cited by this paper
• FcR-Independent Effects of IgE and IgG Autoantibodies in Bullous Pemphigoid

  2011cited by this paper
• Pathogenesis of bullous pemphigoid.

  2011cited by this paper
• Human IgG1 Monoclonal Antibody against Human Collagen 17 Noncollagenous 16A Domain Induces Blisters via Complement Activation in Experimental Bullous Pemphigoid Model

  2010cited by this paper
• Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice

  2010cited by this paper
• What’s new in bullous pemphigoid

  2010cited by this paper
• Circulating IgA and IgE autoantibodies in antilaminin‐332 mucous membrane pemphigoid

  2010cited by this paper
• Blockade of autoantibody-initiated tissue damage by using recombinant fab antibody fragments against pathogenic autoantigen.

  2010cited by this paper
• A Novel Active Mouse Model for Bullous Pemphigoid Targeting Humanized Pathogenic Antigen

  2010cited by this paper
• Ectodomain Shedding Generates Neoepitopes on Collagen XVII, the Major Autoantigen for Bullous Pemphigoid

  2010cited by this paper
• Sequential intramolecular epitope spreading of humoral responses to human BPAG2 in a transgenic model.

  2010cited by this paper
• IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment.

  2009influential reference
• Type XVII collagen is a key player in tooth enamel formation.

  2009cited by this paper
• Bullous pemphigoid: a prototypical antibody-mediated organ-specific autoimmune disease.

  2009cited by this paper
• Humanization of autoantigen: 水疱性類天疱瘡の病態解明と新規治療法開発

  2009influential reference
• A Novel Humanized Neonatal Autoimmune Blistering Skin Disease Model Induced by Maternally Transferred Antibodies1

  2009cited by this paper
• Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.

  2008cited by this paper
• Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.

  2008cited by this paper
• A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy.

  2008cited by this paper
• Immunopathology and molecular diagnosis of autoimmune bullous diseases

  2007cited by this paper
• Humanization of autoantigen

  2007cited by this paper
• Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid

  2007cited by this paper
• Role of different pathways of the complement cascade in experimental bullous pemphigoid.

  2006cited by this paper
• Analysis of the COL17A1 in non-Herlitz junctional epidermolysis bullosa and amelogenesis imperfecta.

  2006cited by this paper
• Synergy between a plasminogen cascade and MMP-9 in autoimmune disease.

  2005cited by this paper
• Collagenous Transmembrane Proteins: Recent Insights into Biology and Pathology*

  2005cited by this paper
• Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid.

  2005cited by this paper
• Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients.

  2004cited by this paper
• Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain.

  2002cited by this paper
• Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid.

  2001cited by this paper
• The extracellular domain of BPAG2 has a loop structure in the carboxy terminal flexible tail in vivo.

  2000cited by this paper
• A critical role for neutrophil elastase in experimental bullous pemphigoid.

  2000cited by this paper
• IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.

  1999cited by this paper
• The 97 kDa linear IgA bullous dermatosis antigen is not expressed in a patient with generalized atrophic benign epidermolysis bullosa with a novel homozygous G258X mutation in COL17A1.

  1998cited by this paper
• Epitope spreading: lessons from autoimmune skin diseases.

  1998cited by this paper
• A major role for neutrophils in experimental bullous pemphigoid.

  1997cited by this paper
• Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies.

  1997cited by this paper
• Mutations in the 180–kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa

  1995cited by this paper
• The role of complement in experimental bullous pemphigoid.

  1995cited by this paper
• Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain.

  1993cited by this paper
• Immunoblotting studies of linear IgA disease.

  1993cited by this paper
• A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.

  1993cited by this paper
• Animal models for bullous pemphigoid.

  1987cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Eosinophil-derived neurotoxin and eosinophil cationic protein are key molecules for blister formation in bullous pemphigoid.

  2025cites this paper
• Targeting antibody-mediated complement-independent mechanism in bullous pemphigoid with diacerein.

  2024cites this paper
• Type XVII collagen-specific CD4+ T cells induce bullous pemphigoid by producing IL-5.

  2024cites this paper
• The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets

  2023cites this paper
• Successful pharmacological intervention at different levels of the complement system in an in vitro complement fixation model for bullous pemphigoid

  2023cites this paper
• Bullous pemphigoid induced by IgG targeting type XVII collagen non‐NC16A/NC15A extracellular domains is driven by Fc gamma receptor‐ and complement‐mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade

  2023cites this paper
• Targeting type 2 inflammation in bullous pemphigoid: current and emerging therapeutic approaches

  2023cites this paper
• Gene expression profiling suggests that complement activation is important for blister formation in bullous pemphigoid.

  2023cites this paper
• Native Autoantigen Complex Detects Pemphigoid Autoantibodies

  2023cites this paper
• Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms

  2022influential citation
• The relevance of complement in pemphigoid diseases: A critical appraisal

  2022cites this paper
• Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients

  2022cites this paper
• Autoantibody:Autoantigen Competitor Decoys: Application to Cardiac Phenotypes

  2022cites this paper
• The pathogeneses of pemphigus and pemphigoid diseases.

  2021cites this paper
• Gene expression profiling of laminin α3‐blocked keratinocytes reveals an immune‐independent mechanism of blistering

  2021cites this paper
• Subunit-Specific Reactivity of Autoantibodies Against Laminin-332 Reveals Direct Inflammatory Mechanisms on Keratinocytes

  2021cites this paper
• Milestones in Personalized Medicine in Pemphigus and Pemphigoid

  2021cites this paper
• Genetic predisposition to bullous pemphigoid.

  2020cites this paper
• Presence of Cutaneous Complement Deposition Distinguishes between Immunological and Histological Features of Bullous Pemphigoid—Insights from a Retrospective Cohort Study

  2020cites this paper
• The differences of collagen XVII between the oral mucosa and the skin discover the pathogenesis of oral lesions in pemphigoid

  2020cites this paper
• Pemphigoid diseases: Insights in the nonbullous variant and disease management

  2020cites this paper
• Dipeptidyl peptidase IV inhibitor-associated bullous pemphigoid: a recently recognized autoimmune blistering disease with unique clinical, immunological and genetic characteristics

  2019cites this paper
• Immune Reaction to Type XVII Collagen Induces Intramolecular and Intermolecular Epitope Spreading in Experimental Bullous Pemphigoid Models

  2019cites this paper
• Specific inhibition of the classical complement pathway prevents C3 deposition along the dermal-epidermal junction in bullous pemphigoid.

  2019cites this paper
• Complement Activation in Autoimmune Bullous Dermatoses: A Comprehensive Review

  2019cites this paper
• Lichen Planus Pemphigoides: From Lichenoid Inflammation to Autoantibody-Mediated Blistering

  2019cites this paper
• Resolution in bullous pemphigoid

  2019cites this paper
• Experimental models of dermatological diseases

  2019influential citation
• The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid

  2019cites this paper
• IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid.

  2019cites this paper
• Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid. Supplementary Materials

  2019cites this paper
• Characteristic Pattern of IL-17RA, IL-17RB, and IL-17RC in Monocytes/Macrophages and Mast Cells From Patients With Bullous Pemphigoid

  2019cites this paper
• Fc‐binding proteins enhance autoantibody‐induced BP180 depletion in pemphigoid

  2019cites this paper
• Экспериментальные модели дерматологических заболеваниий

  2019cites this paper
• Biological therapy of autoimmune blistering diseases

  2019cites this paper
• Bullous Pemphigoid IgG Induces Cell Dysfunction and Enhances the Motility of Epidermal Keratinocytes via Rac1/Proteasome Activation

  2019cites this paper
• The pathogenesis of bullous skin diseases

  2019cites this paper
• Recent advances in the understanding and treatment of pemphigus and pemphigoid

  2018cites this paper
• Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2

  2018cites this paper
• The identification of autoantigens in mucous membrane pemphigoid using immortalized oral mucosal keratinocytes

  2018cites this paper
• Complement Activation in Inflammatory Skin Diseases

  2018cites this paper
• Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients

  2018cites this paper
• Autoantibodies of non‐inflammatory bullous pemphigoid hardly deplete type XVII collagen of keratinocytes

  2017cites this paper
• Bullous pemphigoid.

  2017cites this paper
• Anti-idiotypic Antibodies against BP-IgG Prevent Type XVII Collagen Depletion

  2017cites this paper
• Loss of interaction between plectin and type XVII collagen results in epidermolysis bullosa simplex

  2017cites this paper
• Complement in bullous pemphigoid: results from a large observational study

  2017cites this paper
• Complement Activation Induce Blister Formation without Bullous Pemphigoid Autoantibodies Directly

  2017cites this paper
• IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid.

  2017cites this paper
• C-Terminal Processing of Collagen XVII Induces Neoepitopes for Linear IgA Dermatosis Autoantibodies.

  2017cites this paper
• In vitro and in vivo models to investigate the pathomechanisms and novel treatments for pemphigoid diseases

  2017cites this paper
• Complement‐independent blistering mechanisms in bullous pemphigoid

  2017cites this paper
• BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid

  2017cites this paper
• Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.

  2016cites this paper
• Extracellular cleavage of collagen XVII is essential for correct cutaneous basement membrane formation.

  2016cites this paper
• Eosinophil localization to the basement membrane zone is autoantibody‐ and complement‐dependent in a human cryosection model of bullous pemphigoid

  2016cites this paper
• Collagen-based nanobiomaterials: Challenges in soft tissue engineering

  2016cites this paper
• Epitope-Dependent Pathogenicity of Antibodies Targeting a Major Bullous Pemphigoid Autoantigen Collagen XVII/BP180.

  2016influential citation
• Macropinocytosis of type XVII collagen induced by bullous pemphigoid IgG is regulated via protein kinase C

  2016cites this paper
• Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid.

  2016cites this paper
• Anti-BP180-type mucous membrane pemphigoid immunoglobulin G shows heterogeneity of internalization of BP180/collagen XVII into keratinocyte cytoplasm

  2016cites this paper
• IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid.

  2016cites this paper
• Context-Dependent Regulation of Collagen XVII Ectodomain Shedding in Skin.

  2015cites this paper
• A recombinant fusion protein derived from dog hookworm inhibits autoantibody‐induced dermal–epidermal separation ex vivo

  2015cites this paper
• Plectin-related skin diseases.

  2015cites this paper
• IgE autoantibodies in bullous pemphigoid: supporting role, or leading player?

  2015cites this paper
• Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.

  2014cites this paper
• Bullous Pemphigoid Autoantibodies Directly Induce Blister Formation without Complement Activation

  2014influential citation
• Autoimmune Activation toward Embryo Implantation is Rare in Immune-Privileged Human Endometrium

  2014cites this paper
• Unusual bullous pemphigoid without infiltration of inflammatory cells in the skin lesions

  2014cites this paper
• Clinical Presentation, Pathogenesis, Diagnosis, and Treatment of Epidermolysis Bullosa Acquisita

  2013cites this paper
• Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida

  2013cites this paper
• Pathogenesis of epidermolysis bullosa acquisita.

  2011cites this paper
• Atopic dermatitis and inflammatory skin disease Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects

  year unknowncites this paper
• Differential DNA Methylation of MicroRNA-Encoding Genes in Psoriatic Epidermis Highlights the Wnt Pathway

  year unknowncites this paper